Case Studies in Modern Drug Discovery and Development. Edited by Xianhai Huang and Robert G. Aslanian

ChemMedChem ◽  
2013 ◽  
Vol 8 (4) ◽  
pp. 667-668
Author(s):  
Thomas Ryckmans
Keyword(s):  
Drug Discovery ◽  
Case Studies ◽  
Drug Discovery And Development ◽  
Modern Drug

Translational Medicine – A Paradigm Shift in Modern Drug Discovery and Development

2020 ◽  
pp. 333-345
Author(s):  
Giora Z. Feuerstein ◽  
Salvatore Alesci ◽  
Frank L. Walsh ◽  
J. Lynn Rutkowski ◽  
Robert R. Ruffolo
Keyword(s):  
Drug Discovery ◽  
Paradigm Shift ◽  
Translational Medicine ◽  
Drug Discovery And Development ◽  
Modern Drug

Modern Drug Discovery and Development in the Area of Cancer: Indian Context

2021 ◽  
pp. 227-253
Author(s):  
Tapas K. Kundu ◽  
Anand P. Kulkarni ◽  
Dipak Datta ◽  
Sweta Sikder
Keyword(s):  
Drug Discovery ◽  
Drug Discovery And Development ◽  
Indian Context ◽  
Modern Drug

Biotech–pharma alliances: Strategies, structures and financing

10.5912/jcb91 ◽  
2004 ◽  
Vol 10 (4) ◽  
Author(s):  
Tyzoon Tyebjee ◽  
Jill Hardin
Keyword(s):  
Drug Discovery ◽  
Case Studies ◽  
Financial Instruments ◽  
Drug Discovery And Development ◽  
Development Cycle ◽  
Biotechnology Companies ◽  
Strategic Logic

The drug discovery and development industry is under intense pressure to become more efficient and develop drugs better, faster, cheaper. Consequently, pharmaceutical and biotechnology companies are entering into alliances in an effort to utilise each other's talents, exploit each other's specialisations, and create more value. In this paper, the economics of the drug discovery and development cycle are examined to identify the economic and strategic logic of the alliances. The financial instruments commonly used to structure the alliances are discussed with example case studies.

Sign in / Sign up

Export Citation Format

Share Document